A Study of HB0045 Injection in Patients With Advanced Solid Tumors
NCT06056323
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
71
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor, Adult
Interventions
DRUG:
HB0045 Drug Product
Sponsor
Shanghai Huaota Biopharmaceutical Co., Ltd.
Collaborators
[object Object]
[object Object]
[object Object]